G8 backs HIV vaccine plan

A global program styled on the Human Genome Project gets the nod from world leaders

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

MONTREUX—The world's leading industrial powers have given their support to a US proposal for an international alliance to accelerate HIV vaccine research, US President George Bush announced yesterday (June 10) at the conclusion of the G8 meeting in Sea Island, Georgia.

The idea is to create "a virtual consortium" based on a joint strategic plan, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, told a briefing yesterday. "When other nations… decide they want to align their own resources or put new resources into vaccine development, there will be a strategic plan framework with which they can synergize," he said.

Scientists gathered here in Switzerland at a vaccine development conference warmly welcomed the support for the new "Global HIV Vaccine Enterprise," a concept developed by Richard Klausner and colleagues at the Bill and Melinda Gates Foundation.

José Esparza from the Gates Foundation said: "The G8 statement ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies